XSHG
600319
Market cap364mUSD
Oct 09, Last price
6.32CNY
1D
0.32%
1Q
4.98%
IPO
-48.68%
Name
Weifang Yaxing Chemical Co Ltd
Chart & performance
P/E
—
P/S
2.85
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.85%
Rev. gr., 5y
77.13%
Revenues
859m
-5.60%
Net income
-156m
L+60.95%
CFO
-21m
L
Dividend
Jun 15, 20090.02 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Weifang Yaxing Chemical Co., Ltd. is actively involved in the research, development, manufacturing, and worldwide distribution of a diverse range of chemical products. Its extensive offerings include chlorinated polyethylene (CPE), azodicarbonamide foaming agents, industrial hydrazine hydrate, sodium hydroxide, liquid chlorine, and hydrochloric acid. The company, which has its corporate headquarters in Weifang, China, was established in 1994.
Key people
Xibo Cao
Vice Chairman of the Board · since 2021
Xiuhua Lun
Chief Financial Officer · since 2019
Weidong Lu
General Manager · since 2018
Huanyi Cui
Deputy General Manager · since 2016
Zhenliang Fu
Deputy General Manager · since 2021
Yan Sun
Deputy General Manager · since 2013
Lei Yang
Deputy General Manager · since 2016
Wenqing Li
Secretary of the Board, Director · since 2021
Haibin Han
Chairman of the Board · since 2017
Tengfei Tan
Director · since 2021
Xiuping Wang
Director · since 2021
Zhikun Yan
Director · since 2022
Yueqiang Zhai
Director · since 2021
Xiangchen Fang
Independent Director
Xinggang Fu
Independent Director · since 2021
Xiuli Liu
Independent Director · since 2021
Zhiwen Qi
Independent Director · since 2025
Yanmei Zhao
Independent Director · since 2022
Yi Zhou
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||